Radiotherapy for newly diagnosed malignant glioma in adults: a systematic review (Q33184436)

23 July 2017

1 reference

title

Radiotherapy for newly diagnosed malignant glioma in adults: a systematic review (English)

1 reference

Adaptive radiation therapy

23 July 2017

0 references

1 reference

Normand J. Laperriere

object named as

Normand Laperriere

series ordinal

1

0 references

J Gregory Cairncross

series ordinal

3

object named as

Gregory Cairncross

1 reference

23 July 2017

Lisa Zuraw

2

1 reference

PubMed ID

12242114

23 July 2017

Cancer Care Ontario Practice Guidelines Initiative Neuro-Oncology Disease Site Group

series ordinal

4

1 reference

23 July 2017

1 September 2002

1 reference

Radiotherapy and Oncology

23 July 2017

1 reference

23 July 2017

64

1 reference

23 July 2017

3

1 reference

23 July 2017

259-273

1 reference

Postoperative Irradiation of Glioblastomas: Results in a Randomized Series

23 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900078-6

7 January 2021

A prospective study of short-course radiotherapy in poor prognosis glioblastoma multiforme.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900078-6

7 January 2021

A randomized study of misonidazole and radiotherapy for grade 3 and 4 cerebral astrocytoma

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900078-6

7 January 2021

A Medical Research Council trial of two radiotherapy doses in the treatment of grades 3 and 4 astrocytoma. The Medical Research Council Brain Tumour Working Party

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900078-6

7 January 2021

Modifying radical radiotherapy in high grade gliomas; shortening the treatment time through acceleration.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900078-6

7 January 2021

Linac radiosurgery for high-grade gliomas: the University of Florida experience.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900078-6

7 January 2021

Accelerated radiotherapy regimen for malignant gliomas using stereotactic concomitant boosts for dose escalation

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900078-6

7 January 2021

Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas. A joint Radiation Therapy Oncology Group and Eastern Cooperative Oncology Group study

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900078-6

7 January 2021

Adverse effects of brain irradiation correlated with MR and CT imaging.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900078-6

7 January 2021

White matter changes are correlated significantly with radiation dose. Observations from a randomized dose-escalation trial for malignant glioma (Radiation Therapy Oncology Group 83-02)

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900078-6

7 January 2021

Magnetic resonance imaging of cranial radiation lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900078-6

7 January 2021

Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900078-6

7 January 2021

Survival comparison of radiosurgery-eligible and -ineligible malignant glioma patients treated with hyperfractionated radiation therapy and carmustine: a report of Radiation Therapy Oncology Group 83-02

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900078-6

7 January 2021

Meta-analysis in clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900078-6

7 January 2021

Results of a randomized trial comparing BCNU plus radiotherapy, streptozotocin plus radiotherapy, BCNU plus hyperfractionated radiotherapy, and BCNU following misonidazole plus radiotherapy in the postoperative treatment of malignant glioma

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900078-6

7 January 2021

Report of a randomised pilot study of the treatment of patients with supratentorial gliomas using neutron irradiation.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900078-6

7 January 2021

The results of a randomised trial of mixed-schedule (neutron/photon) irradiation in the treatment of supratentorial Grade III and Grade IV astrocytoma

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900078-6

7 January 2021

Misonidazole in radiotherapy of supratentorial malignant brain gliomas in adult patients: a randomized double-blind study

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900078-6

7 January 2021

A short fractionation radiotherapy treatment for poor prognosis patients with high grade glioma.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900078-6

7 January 2021

Misonidazole combined with hyperfractionation in the management of malignant glioma

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900078-6

7 January 2021

Stereotactic radiosurgery as an adjunct to surgery and external beam radiotherapy in the treatment of patients with malignant gliomas

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900078-6

7 January 2021

Postoperative hypofractionated radiotherapy versus conventionally fractionated radiotherapy in malignant gliomas. A preliminary report on a randomized trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900078-6

7 January 2021

Combined modality treatment of operated astrocytomas grade 3 and 4. A prospective and randomized study of misonidazole and radiotherapy with two different radiation schedules and subsequent CCNU chemotherapy. Stage II of a prospective multicenter tr

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900078-6

7 January 2021

Assumptions in the radiotherapy of glioblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900078-6

7 January 2021

A prospective study of short course radiotherapy in elderly patients with malignant glioma.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900078-6

7 January 2021

European Organization for Research on Treatment of Cancer trials using radiotherapy with multiple fractions per day. A 1978-1987 survey

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900078-6

7 January 2021

Intratumoral oxygen pressure in malignant brain tumor

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900078-6

7 January 2021

Survival and quality of life after continuous accelerated radiotherapy of glioblastomas.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900078-6

7 January 2021

Short course radiotherapy is an appropriate option for most malignant glioma patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900078-6

7 January 2021

Survival benefit of stereotactic radiosurgery for patients with malignant glial neoplasms.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900078-6

7 January 2021

Combined modality therapy of operated astrocytomas grade III and IV. Confirmation of the value of postoperative irradiation and lack of potentiation of bleomycin on survival time: a prospective multicenter trial of the Scandinavian Glioblastoma Stud

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900078-6

7 January 2021

Randomized study of brachytherapy in the initial management of patients with malignant astrocytoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900078-6

7 January 2021

Randomized neutron dose searching study for malignant gliomas of the brain: results of an RTOG study. Radiation Therapy Oncology Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900078-6

7 January 2021

Radiation Therapy Oncology Group (RTOG) survival data on anaplastic astrocytomas of the brain: does a more aggressive form of treatment adversely impact survival?

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900078-6

7 January 2021

Gamma knife for glioma: selection factors and survival

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900078-6

7 January 2021

Radiation therapy for neoplasms of the brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900078-6

7 January 2021

Radiosurgery for glioblastoma multiforme: the importance of selection criteria.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900078-6

7 January 2021

Superfractionated radiotherapy in grade III, IV intracranial gliomas

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900078-6

7 January 2021

Stereotactic radiosurgery for glioblastoma: a final report of 31 patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900078-6

7 January 2021

Stereotactic radiosurgery for glioblastoma multiforme: report of a prospective study evaluating prognostic factors and analyzing long-term survival advantage

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900078-6

7 January 2021

A study of the effect of misonidazole in conjunction with radiotherapy for the treatment of grades 3 and 4 astrocytomas. A report from the MRC Working Party on misonidazole in gliomas

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900078-6

7 January 2021

Hyperfractionated radiation therapy and bis-chlorethyl nitrosourea in the treatment of malignant glioma--possible advantage observed at 72.0 Gy in 1.2 Gy B.I.D. fractions: report of the Radiation Therapy Oncology Group Protocol 8302.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900078-6

7 January 2021

A randomized comparison of misonidazole sensitized radiotherapy plus BCNU and radiotherapy plus BCNU for treatment of malignant glioma after surgery: final report of an RTOG study.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900078-6

7 January 2021

Survival and prognosis of patients with astrocytoma with atypical or anaplastic features.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900078-6

7 January 2021

Malignant astrocytoma. Hyperfractionated and standard radiotherapy with chemotherapy in a randomized prospective clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900078-6

7 January 2021

Pion radiation for high grade astrocytoma: results of a randomized study.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900078-6

7 January 2021

A phase 3 randomized study of radiotherapy plus procarbazine, CCNU, and vincristine (PCV) with or without BUdR for the treatment of anaplastic astrocytoma: a preliminary report of RTOG 9404.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900078-6

7 January 2021

Direct measurement of pO2 distribution and bioreductive enzymes in human malignant brain tumors.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900078-6

7 January 2021

A randomized study of chemotherapy with procarbazine, vincristine, and lomustine with and without radiation therapy for astrocytoma grades 3 and/or 4.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900078-6

7 January 2021

Radiosurgery in the initial management of malignant gliomas: survival comparison with the RTOG recursive partitioning analysis. Radiation Therapy Oncology Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900078-6

7 January 2021

Treatment of malignant glioma. A controlled study of chemotherapy and irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900078-6

7 January 2021

Randomized trial of three chemotherapy regimens and two radiotherapy regimens and two radiotherapy regimens in postoperative treatment of malignant glioma. Brain Tumor Cooperative Group Trial 8001.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900078-6

7 January 2021

Radiosurgery and accelerated radiotherapy for patients with glioblastoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900078-6

7 January 2021

Superfractionation radiation therapy in the treatment of malignant astrocytoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900078-6

7 January 2021

Multiple daily fractionated radiation therapy and misonidazole in the management of malignant astrocytoma. A preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900078-6

7 January 2021

Treatment of patients with primary glioblastoma multiforme with standard postoperative radiotherapy and radiosurgical boost: prognostic factors and long-term outcome.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900078-6

7 January 2021

Hypofractionated radiation therapy in patients with glioblastoma multiforme: results of treatment and impact of prognostic factors.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900078-6

7 January 2021

Survival benefit of hyperthermia in a prospective randomized trial of brachytherapy boost +/- hyperthermia for glioblastoma multiforme.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900078-6

7 January 2021

Hyperfractionated radiotherapy of human tumors: overview of the randomized clinical trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900078-6

7 January 2021

Misonidazole and irradiation in the treatment of high-grade astrocytomas: Further report of the Vienna study group

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900078-6

7 January 2021

Hypofractionated radiotherapy as palliative treatment in poor prognosis patients with high grade glioma.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900078-6

7 January 2021

Radiation and High-Dose Metronidazole in Supratentorial Glioblastomas

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900078-6

7 January 2021

Radiation and nitroimidazoles in supratentorial high grade gliomas: a second clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900078-6

7 January 2021

Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900078-6

7 January 2021

Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900078-6

7 January 2021

Patterns of failure following treatment for glioblastoma multiforme and anaplastic astrocytoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900078-6

7 January 2021

10.1016/S0167-8140(02)00078-6

Identifiers

DOI

1 reference

23 July 2017

1 reference

PubMed ID

12242114